The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 31, 2020

Filed:

May. 30, 2018
Applicant:

Boehringer Ingelheim International Gmbh, Ingelheim am Rhein, DE;

Inventors:

Kenji Egusa, Ikeda, JP;

Takuma Katayama, Kobe, JP;

Kazutoshi Yokoyama, Osaka, JP;

Remko Alexander Bakker, Biberach an der Riss, DE;

Ngai Hang Victor Chong, Heidesheim, DE;

Joerg Rippmann, Schemmerhofen, DE;

Assignee:

Boehringer Ingelheim International GmbH, Ingelheim am Rhein, DE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/166 (2006.01); A61K 9/20 (2006.01); A61P 1/16 (2006.01); A61P 27/02 (2006.01); A61P 35/00 (2006.01); A61P 3/00 (2006.01); A61P 29/00 (2006.01); A61K 9/28 (2006.01);
U.S. Cl.
CPC ...
A61K 31/166 (2013.01); A61K 9/2013 (2013.01); A61K 9/2018 (2013.01); A61K 9/2059 (2013.01); A61P 1/16 (2018.01); A61P 3/00 (2018.01); A61P 27/02 (2018.01); A61P 29/00 (2018.01); A61P 35/00 (2018.01); A61K 9/2095 (2013.01); A61K 9/28 (2013.01);
Abstract

The present invention relates to pharmaceutical compositions comprising (E)-4-(2-(aminomethyl)-3-fluoroallyloxy)-N-tert-butylbenzamide having the following chemical structure or a pharmaceutically acceptable salt thereof as active pharmaceutical ingredient, particularly to pharmaceutical compositions comprising (E)-4-(2-(aminomethyl)-3-fluoroallyloxy)-N-tert-butylbenzamide hydrochloride, to pharmaceutical dosage forms, to their preparation, their use and methods for therapeutic treatment.


Find Patent Forward Citations

Loading…